You are here: All Products  > Lynk Doses First Cohort of Psoriasis Patients with Topical Third-Gen JAK Inhibitor

Lynk Doses First Cohort of Psoriasis Patients with Topical Third-Gen JAK Inhibitor

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.